Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Post by hassyon Mar 14, 2013 4:39pm
220 Views
Post# 21131823

Deals

Deals

Seriously guys this used to be the place I visit for info but lately it had been pretty disappointing....

the fact is our science worked so far. And the fact that there are two potential valuations for us in short term 1) license 2) buyout 

with shire theirs interest is to drag out for as long as possible to de-risk their investment. Understandable but obviously not to our advantage.  IMHO we would be much much better off striking a deal under competition not wait for one party (shire) 

Knowing science work I am happy. Who cares about the validity of a publication (or how an individual drug work/ not work) bti is a technology and the technology works. The demand for the technology is there.

For the record, I topped up my position yesterday and today between 1.45-1.49 for another 30k shares.

H

 

 

Bullboard Posts